155 related articles for article (PubMed ID: 34590011)
1. Impact of a Lymph Node Specimen Collection Kit on the Distribution and Survival Implications of the Proposed Revised Lung Cancer Residual Disease Classification: A Propensity-Matched Analysis.
Smeltzer MP; Faris NR; Fehnel C; Akinbobola O; Saulsberry A; Meadows-Taylor M; Pacheco A; Ray M; Osarogiagbon RU
JTO Clin Res Rep; 2021 Apr; 2(4):100161. PubMed ID: 34590011
[TBL] [Abstract][Full Text] [Related]
2. Beyond Margin Status: Population-Based Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification Recategorization.
Osarogiagbon RU; Faris NR; Stevens W; Fehnel C; Houston-Harris C; Ojeabulu P; Akinbobola OA; Lee YS; Ray MA; Smeltzer MP
J Thorac Oncol; 2020 Mar; 15(3):371-382. PubMed ID: 31783180
[TBL] [Abstract][Full Text] [Related]
3. The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer.
Edwards JG; Chansky K; Van Schil P; Nicholson AG; Boubia S; Brambilla E; Donington J; Galateau-Sallé F; Hoffmann H; Infante M; Marino M; Marom EM; Nakajima J; Ostrowski M; Travis WD; Tsao MS; Yatabe Y; Giroux DJ; Shemanski L; Crowley J; Krasnik M; Asamura H; Rami-Porta R;
J Thorac Oncol; 2020 Mar; 15(3):344-359. PubMed ID: 31731014
[TBL] [Abstract][Full Text] [Related]
4. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
[TBL] [Abstract][Full Text] [Related]
5. Outcomes After Use of a Lymph Node Collection Kit for Lung Cancer Surgery: A Pragmatic, Population-Based, Multi-Institutional, Staggered Implementation Study.
Osarogiagbon RU; Smeltzer MP; Faris NR; Ray MA; Fehnel C; Ojeabulu P; Akinbobola O; Meadows-Taylor M; McHugh LM; Halal AM; Levy P; Sachdev V; Talton D; Wiggins L; Shu XO; Shyr Y; Robbins ET; Klesges LM
J Thorac Oncol; 2021 Apr; 16(4):630-642. PubMed ID: 33607311
[TBL] [Abstract][Full Text] [Related]
6. [The impact of uncertainty resection on the prognosis of non-small cell lung cancer].
Zhang N; Zhang SW; Han J; Wang Z; Rong Y; Liu JF
Zhonghua Wai Ke Za Zhi; 2024 Jun; 62(8):764-770. PubMed ID: 38937128
[No Abstract] [Full Text] [Related]
7. Comparative Effectiveness of a Lymph Node Collection Kit Versus Heightened Awareness on Lung Cancer Surgery Quality and Outcomes.
Ray MA; Fehnel C; Akinbobola O; Faris NR; Taylor M; Pacheco A; Smeltzer MP; Osarogiagbon RU
J Thorac Oncol; 2021 May; 16(5):774-783. PubMed ID: 33588112
[TBL] [Abstract][Full Text] [Related]
8. Prognostic evaluation of the proposed residual tumor classification in a Chinese non-small cell lung cancer population.
Ren Y; She Y; Tang H; Deng J; Jiang G; Wu C; Zhu Y; Zheng H; Chen C
J Surg Oncol; 2022 May; 125(6):1061-1070. PubMed ID: 35099810
[TBL] [Abstract][Full Text] [Related]
9. Validation of the IASLC Residual Tumor Classification in Patients With Stage III-N2 Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiotherapy Followed By Surgery.
Lee J; Lee J; Hong YS; Lee G; Kang D; Yun J; Jeon YJ; Shin S; Cho JH; Choi YS; Kim J; Zo JI; Shim YM; Guallar E; Cho J; Kim HK
Ann Surg; 2023 Jun; 277(6):e1355-e1363. PubMed ID: 35166266
[TBL] [Abstract][Full Text] [Related]
10. A Validation Study of the Recommended Change in Residual Tumor Descriptors Proposed by the International Association for the Study of Lung Cancer for Patients With pN2 NSCLC.
Yun JK; Lee GD; Choi S; Kim YH; Kim DK; Park SI; Kim HR
J Thorac Oncol; 2021 May; 16(5):817-826. PubMed ID: 33607310
[TBL] [Abstract][Full Text] [Related]
11. Residual tumor descriptors proposed by the International Association for the Study of Lung Cancer may not be applicable to stage I and ground-glass opacity-featured non-small cell lung cancer.
Wen Z; Fu F; Zhao Y; Gao Z; Han H; Li H; Ye T; Hu H; Sun Y; Li Y; Zhang Y; Chen H
Transl Lung Cancer Res; 2023 Nov; 12(11):2157-2168. PubMed ID: 38090514
[TBL] [Abstract][Full Text] [Related]
12. Institution-Level Evolution of Lung Cancer Resection Quality With Implementation of a Lymph Node Specimen Collection Kit.
Akinbobola O; Ray MA; Fehnel C; Saulsberry A; Dortch K; Smeltzer M; Faris NR; Osarogiagbon RU
J Thorac Oncol; 2023 Jul; 18(7):858-868. PubMed ID: 36931504
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of the Proposed Residual Tumor Classification in Patients With NSCLC After Sleeve Lobectomy.
Chen T; Zhong Y; Wen J; Deng J; She Y; Zhu Y; Chen Q; Wu C; Hou L; Jiang L; Chen C
JTO Clin Res Rep; 2023 Oct; 4(10):100574. PubMed ID: 37822700
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Uncertain Resection for Overall Survival in Non-small Cell Lung Cancer.
Kadomatsu Y; Nakamura S; Ueno H; Goto M; Ozeki N; Fukumoto K; Fukui T; Suzuki Y; Chen-Yoshikawa TF
Ann Thorac Surg; 2022 Oct; 114(4):1262-1268. PubMed ID: 34474024
[TBL] [Abstract][Full Text] [Related]
15. Use of a surgical specimen-collection kit to improve mediastinal lymph-node examination of resectable lung cancer.
Osarogiagbon RU; Miller LE; Ramirez RA; Wang CG; O'Brien TF; Yu X; Khandekar A; Schoettle GP; Robbins SG; Robbins ET; Gibson JB
J Thorac Oncol; 2012 Aug; 7(8):1276-82. PubMed ID: 22653076
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of uncertain resection for metastasis in the highest mediastinal lymph node after surgery for clinical N0 non-small cell lung cancer.
Marziali V; Frasca L; Ambrogi V; Patirelis A; Longo F; Crucitti P
Front Surg; 2023; 10():1115696. PubMed ID: 37396297
[TBL] [Abstract][Full Text] [Related]
17. R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer.
Demir IE; Jäger C; Schlitter AM; Konukiewitz B; Stecher L; Schorn S; Tieftrunk E; Scheufele F; Calavrezos L; Schirren R; Esposito I; Weichert W; Friess H; Ceyhan GO
Ann Surg; 2018 Dec; 268(6):1058-1068. PubMed ID: 28692477
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification to Upgrade Extracapsular Extension of Tumor in Nodes From R0 to Incomplete Resection.
Xie H; Dai C; Gu C; Zhao S; Xu L; Wang F; Gao J; Su H; Wu J; She Y; Ren Y; Wu C; Chen C
J Thorac Oncol; 2024 Jan; 19(1):130-140. PubMed ID: 37567388
[TBL] [Abstract][Full Text] [Related]
19. Audit of lymphadenectomy in lung cancer resections using a specimen collection kit and checklist.
Osarogiagbon RU; Sareen S; Eke R; Yu X; McHugh LM; Kernstine KH; Putnam JB; Robbins ET
Ann Thorac Surg; 2015 Feb; 99(2):421-7. PubMed ID: 25530090
[TBL] [Abstract][Full Text] [Related]
20. Impact of Omission of Intrapulmonary Lymph Node Retrieval on Outcome Evaluation of Lung Cancer Patients Without Lymph Node Metastasis: A Propensity Score Matching Analysis.
Wang X; Yan S; Lv C; Wang Y; Wang J; Li S; Zhang L; Yang Y; Wu N
Clin Lung Cancer; 2017 Nov; 18(6):e411-e416. PubMed ID: 28576593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
